期刊文献+

和肽素在临床危急重症中的应用进展 被引量:6

下载PDF
导出
摘要 和素肽(copeptin)是精氨酸加压素前体的羧基肽部分,与精氨酸加压素等摩尔释放,稳定性好、方便检测,可作为精氨酸加压素的替代物用于临床检测.近年研究发现,和肽素作为一种新的生物标记物,在多种疾病的早期诊断、病情评估以及预后评价方面具有重要的临床价值.本研究对和肽素在常见急危重症中的临床应用及价值作以综述.
作者 沈鹏
出处 《转化医学电子杂志》 2015年第8期125-127,共3页 E-Journal of Translational Medicine
基金 天津市卫生局科技基金(2013KY06)
  • 相关文献

参考文献30

  • 1Charmandari E,Tsigos C,Chromos G. Endocrinology of the stressresponse[J]. Annu Rev Physiol,2005,67:259-284.
  • 2Katan M,Morgenthaler N,Widmer I,et al. Copeptin, a stable peptidederived from the vasopressin precursor correlates with the individualstress level[J]. Neuro Endocrinol Lett,2008,29(3):34l-346.
  • 3Elshafei A,Abdalla G,El.Motaal OA,et al. Copeptin: a neuroendo.crine biomarker in acute myocardial infarction[J]. Annu Rev ResBiol,2013,3(4):1040-1054.
  • 4Morgenthaler NG,Struck J,Alonso C,et al. Assay for the measure.ment of copeptin, a stable peptide derived from the precursor ofvasopressin[J]. Clin Chem,2006,52(1):112-119.
  • 5Holwerda DA. A glycopeptide from the posterior lobe of pigpituitaries.I. Isolation and characterization [J]. Eur J Biochem,1972,28(3):334-339.
  • 6Tousoulis D, Kampoli AM, Stefanadi E, et al. New biochemicalmarkers in acute coronary syndromes[J]. Curr Med Chem,2008,15(13):1288-1296.
  • 7Marston NA,Maisel AS. The prognostic value of copeptin in patientswith acute chest pain [J]. Expert Rev Cardiovasc Ther, 2014,12(10):1237-1242.
  • 8Reichlin T,Hochholzer W,Stelzig C, et al. Incremental value ofcopeptin for rapid rule out of acute myocardial infarction[J]. J AmColl Cardiol,2009,54(1):60-68.
  • 9Thelin J,Borna C,Erlinge D,et al. The combination of high sensitivitytroponin T and copeptin facilitates early rule.out of ACS:a prospec.tive observational study[J].BMC Cardiovasc Disord,2013,13:42.
  • 10Afzali D, Erren M, Pavenstadt HJ, et al. Impact of copeptin ondiagnosis, risk stratification, and intermediate.term prognosis ofacute coronary syndromes[J]. Clin Res Cardiol,2013,102 (10):755-763.

二级参考文献38

  • 1史晓敏,徐国宾,夏铁安.N末端B型钠尿肽原对充血性心力衰竭患者预后及危险分层评价的价值[J].中华检验医学杂志,2006,29(1):27-30. 被引量:56
  • 2杜晓冬,陈瑶,邹利群.血胆碱酯酶对急性有机磷中毒患者病情评估的意义[J].现代预防医学,2007,34(7):1391-1391. 被引量:7
  • 3hoi K, Jiang YQ, Iwasaki Y, et al. Regulatory meehanisras of eortieotropin releasing hormone and vasopressin gene expression in the hypothalamus. Neuroendoerinol, 2004, 16: 348-355.
  • 4Tentzeris I, Jari R, Farhan S, et al. Cnmp[ementary role of eopeptin and high -senditivity troponin in predicting out:ome in patients with stable ehronie hearts failure. J Clin Endoerinol Metab, 2011,121:11-117.
  • 5Alehagen U, Dahlstr MU, Rrhfeld JF, et al. Assciation of eopeptin and N-Terminal proBNP concentration with risk of cardiovascular death io older patients with symptoms of heart failure. J Clin Endcrinol Metab, 2011,305: 2088-2095.
  • 6Bettencourt P, Azevedo A, Pimenta J, et al. N-terminal pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failurre patients. Circulation, 2004, 110: 2168-2174.
  • 7Rossi GP. Arginine wsopressin receptor antagonists for heart failure. J Am Coil Cardiol, 2007, 49: 2160-2162.
  • 8Gawarammana IB, Buckley NA. Medical management of paraquat ingestion [J]. Br J Clin Pharmacol, 2011, 72 (5) : 745 -757.
  • 9Katan M, Christ-Crain M. The stress hormone copeptin:new prognostic biomarker in acute illness [J]. Swiss Med Wkiy, 2010, 140:W13101.
  • 10Min YG, Ahn JH, Chart YC, et al. Prediction of prognosis in acute Paraquat poisoning using severity scoring system in emergency department [J]. Clin Toxicol (Phila), 2011, 49 (9) : 840-845.

共引文献148

同被引文献65

  • 1陈灏珠.心房颤动诊断与治疗的进展和展望[J].中国实用内科杂志:临床前沿版,2006,26(1):82-85. 被引量:44
  • 2张金男,高宇飞,赵丛海,王立坤,赵勇.神经外科术后中枢性尿崩症ADH变化曲线及其临床意义[J].吉林大学学报(医学版),2006,32(6):1087-1090. 被引量:4
  • 3无.儿童社区获得性肺炎管理指南(试行)(下)[J].中华儿科杂志,2007,45(3):223-230. 被引量:207
  • 4NICKEL C H, BING|SSER R, MORGENTHALER N G. The role of copeptin as a diagnostic and prognostic biomarker for risk strati- fication in the emergency department[ J]. BMC Med, 2012, 10: 7.
  • 5KATAN M, MORGENTHALER N, WIDMER I, et al. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stl~ss level[J]. Neuro Endocrinol Lett, 2008, 29(3) : 341 -346.
  • 6BOECK L, EGGIMANN P, SMYRNIOS N, et al. The Sequential Organ Failure Assessment score and copeptin for predicting surviv- al in ventilator- associated pneumonia[J]. J Crit Care 2012, 27 (5) : 523.
  • 7DU J M, SANG G, JIANG C M, et al. Relationship between plas- ma copeptin levels and complications of community - acquired pneumonia i~a preschool children [ J ]. Peptides, 2013, 45 : 61 - 65.
  • 8WROTEK A, JACKOWSKA T, PAWLIK K. Sodium and copeptin levels in children with comnmnity acquired pneumonia [ J ]. Adv Exp Med Bio|, 2015, 835:31 -36.
  • 9NICKEL C H, BINGISSER R, MORGENTHALER N G. The role of copeptin as a diagnostic and prognostic biomarker for risk strati- fication in the emergency department[J]. BMC Med, 2012, 10: 7.
  • 10BOLIGNANO D, CABASSI A, FIACCADOR1 E, et al. Copeptin ( CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology [ J ]. Clin Chem Lab Med, 2014, 52 (10) : 1447 - 1456.

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部